<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02608463</url>
  </required_header>
  <id_info>
    <org_study_id>204737</org_study_id>
    <nct_id>NCT02608463</nct_id>
  </id_info>
  <brief_title>Neuropathic Pain in Pregnancy</brief_title>
  <official_title>Neuropathic Pain in Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be the first study to investigate the use of rTMS in the treatment of neuropathic&#xD;
      pain in pregnancy. This study will enroll 60 pregnant subjects, age 18-45. All participants&#xD;
      will receive treatment as usual. Subjects diagnosed with neuropathic pain will be offered&#xD;
      rTMS as a treatment option.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neuropathic pain is a common pain disorder that is caused by problems in the nervous system.&#xD;
      It affects more women than men and commonly occurs in pregnancy. Physicians have little&#xD;
      information to guide their treatment of neuropathic pain in pregnancy. The overall goal of&#xD;
      this study is to define the course, management, and pregnancy outcomes of neuropathic pain in&#xD;
      pregnancy and the acute postpartum period. It is difficult to manage neuropathic pain in&#xD;
      pregnancy as treatment options must minimize their risk to the unborn child as they have a&#xD;
      direct effect on infant outcomes through their exposure in utero. Thus, other treatments are&#xD;
      needed. Repetitive transcranial magnetic stimulation (rTMS) may be an acceptable alternative&#xD;
      to medications. Transcranial magnetic stimulation uses a magnetic force to change the way&#xD;
      nerves work in the brain. This non-invasive and localized mechanism of action makes it&#xD;
      attractive for use in special populations, such as pregnancy. Study visits will occur&#xD;
      approximately every 4-6 weeks during pregnancy until approximately 3 months postpartum for a&#xD;
      maximum of 12 visits.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">April 19, 2019</completion_date>
  <primary_completion_date type="Actual">April 19, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>All subjects will participate in Part A, receive standard of care and complete the painDETECT Questionnaire (PDQ) to be assigned to 1 of 3 groups based on the PDQ score.&#xD;
Subjects in Part A will complete the following at study entry and each study visit: the Beck Depression Inventory (BDI), Visual Analogue Scale (VAS), Pain Catastrophizing Scale (PCS), and measures of pain intensity, interference, behavior. At each visit after study entry, subjects will complete the Patients' Global Impression of Change scale (PGIC); clinicians will complete the Clinical Global Impression-Global Improvement scale (CGI-I).&#xD;
Subjects in Part B will receive rTMS and be followed daily until day 29 after last rTMS session. For each session, subjects will complete a VAS prior, immediately after, and 60 minutes post, day 22 &amp; day 29; a BDI on Days 1, 5, 12, 22, &amp; 29; on days 5, 12, 22, &amp; 29 subjects will complete the PGIC; clinicians will complete the CGI-I.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline Visual Analogue Scale for Pain</measure>
    <time_frame>Baseline and end of study participation, an average of 194 days</time_frame>
    <description>100 mm line scale that is subject administered to subjectively rate current pain symptoms. The subject will be instructed to draw a single vertical line that best describes current state. The total score ranges from 0-100 with higher numbers indicating worse outcomes. The VAS will be administered at every subject visit.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Pain</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Part A - Neuropathic Pain</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects with a score of ≥ 13 on the painDETECT Questionnaire (PDQ) will be assigned to the Neuropathic Pain group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part A - Non-Neuropathic Pain</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects with a score of ≥ 1 or ≤ 12 on the painDETECT Questionnaire (PDQ) will be assigned to the Non-Neuropathic Pain group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part A - Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects with a score of score = 0 on the painDETECT Questionnaire (PDQ) will be assigned to the Control group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part B - rTMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects from the Neuropathic Pain group will be invited to participate in the Part B rTMS group to receive repetitive transcranial magnetic stimulation (rTMS).</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>painDETECT Questionnaire</intervention_name>
    <description>This self-report questionnaire consists of 7 questions that address the quality of neuropathic pain syndromes. The first 5 questions ask about the gradation of pain, question 6 asks about the pain course pattern and question 7 asks about radiating pain. There are 4 additional questions (not counted in the total score) which asks the subject to rate their pain now and over the last 4 weeks and to mark on a body chart if there is pain radiating into other parts of the body.</description>
    <arm_group_label>Part A - Control</arm_group_label>
    <arm_group_label>Part A - Neuropathic Pain</arm_group_label>
    <arm_group_label>Part A - Non-Neuropathic Pain</arm_group_label>
    <other_name>PDQ</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pain Catastrophizing Scale</intervention_name>
    <description>The PCS is a 13-item self-report scale. It asks subjects to reflect on past painful experiences, and to indicate the degree to which they experienced each of 13 thoughts or feelings when experiencing pain, on 5-point scales with the end points (0) not at all and (4) all the time. The PCS yields a total score and three subscale scores assessing rumination, magnification, and helplessness.</description>
    <arm_group_label>Part A - Control</arm_group_label>
    <arm_group_label>Part A - Neuropathic Pain</arm_group_label>
    <arm_group_label>Part A - Non-Neuropathic Pain</arm_group_label>
    <other_name>PCS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pain Intensity Scale, Pain Interference Scale, Pain Behavior Scale</intervention_name>
    <description>The 3-item, self-report Pain Intensity assesses how much a person hurts. The first 2 items assess pain intensity over the past 7 days; the last item asks subject to rate pain intensity &quot;right now.&quot; The 4-item, self-report Pain Interference measures the consequences of pain on relevant aspects of subject's life. It includes impairment in subject's social, cognitive, emotional, physical, &amp; recreational activities. It also incorporates items about sleep and enjoyment of life. It assesses pain interference over the past 7 days.&#xD;
The 7-item, self-report Pain Behavior measures behaviors that typically indicate to others that an individual is experiencing pain. Measures include observations (sighing, crying), behaviors (resting, guarding, facial expressions, asking for help), &amp; verbal reports of pain. It assesses pain interference over the past 7 days.&#xD;
All three scales, derived from the Patient Reported Outcomes Measurement Information System (PROMIS), are not disease specific.</description>
    <arm_group_label>Part A - Control</arm_group_label>
    <arm_group_label>Part A - Neuropathic Pain</arm_group_label>
    <arm_group_label>Part A - Non-Neuropathic Pain</arm_group_label>
    <other_name>Pain Measures</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Beck Depression Inventory</intervention_name>
    <description>The BDI is a widely used instrument that has been used in both clinical and non-clinical setting measuring depressive symptoms. It is a 21 item questionnaire with 4-5 responses for each question. Responses are coded 0-3 for the 4 point scales. The 5 point scales include an additional 2a and 2b response code. The symptom categories reflect overt behavioral manifestations of depression. The instrument has both a high degree of reliability and validity (Beck, Ward, Mendelson, Mock &amp; Erbaugh, 1961).</description>
    <arm_group_label>Part A - Control</arm_group_label>
    <arm_group_label>Part A - Neuropathic Pain</arm_group_label>
    <arm_group_label>Part A - Non-Neuropathic Pain</arm_group_label>
    <arm_group_label>Part B - rTMS</arm_group_label>
    <other_name>BDI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Visual Analogue Scale</intervention_name>
    <description>100 mm line scale that is subject administered to subjectively rate current pain symptoms. The subject will be instructed to draw a single vertical line that best describes current state.</description>
    <arm_group_label>Part A - Control</arm_group_label>
    <arm_group_label>Part A - Neuropathic Pain</arm_group_label>
    <arm_group_label>Part A - Non-Neuropathic Pain</arm_group_label>
    <arm_group_label>Part B - rTMS</arm_group_label>
    <other_name>VAS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Patient's Global Impression of Change Scale &amp; Clinical Global Impression-Global Improvement Scale</intervention_name>
    <description>The PGIC gives a global rating of change in symptoms, activities, emotion, and overall quality of life related to the subject's pain condition. This is a self-rated scale.&#xD;
The CGI-I gives a global rating of the improvement/change in the symptoms since the last study visit. This is administered by the MD.</description>
    <arm_group_label>Part A - Control</arm_group_label>
    <arm_group_label>Part A - Neuropathic Pain</arm_group_label>
    <arm_group_label>Part A - Non-Neuropathic Pain</arm_group_label>
    <arm_group_label>Part B - rTMS</arm_group_label>
    <other_name>PGIC &amp; CGI-I</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation</intervention_name>
    <description>Subjects will undergo daily repetitive transcranial magnetic stimulation (rTMS), defined as Monday through Friday, for a total of 10 consecutive sessions. rTMS will be applied using the NeuroStar TMS Therapy System through a figure-8 coil connected to a magnetic stimulator, which provides a biphasic pulse. The coil is applied to the primary motor cortex, M1, contralateral to the painful side. The optimal stimulus site, motor hot spot, will be determined according to visual detection of muscle twitches, and a resting motor threshold is defined as the minimal intensity necessary to induce at least one visible muscle twitch. An rTMS session consists of 10 trains at 90% intensity of resting motor threshold (one train, 100 pulses at 10 Hz; intertrain interval, 50s).</description>
    <arm_group_label>Part B - rTMS</arm_group_label>
    <other_name>NeuroStar® TMS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Part A&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18-45 years old,&#xD;
&#xD;
          -  ability to give informed consent,&#xD;
&#xD;
          -  viable pregnancy, and&#xD;
&#xD;
          -  enrollment prior or equal to 24 weeks gestation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active or history of substance use disorder within the past year&#xD;
&#xD;
          -  Non-English speaking&#xD;
&#xD;
        Part B&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects enrolled in Part A and willing to consent to Part B of this protocol&#xD;
&#xD;
          -  Pregnant with current chronic neuropathic pain&#xD;
&#xD;
          -  Subjects failed treatment with amitriptyline or nortriptyline as defined by one of the&#xD;
             following:&#xD;
&#xD;
               -  no clinical improvement following a 4-week trial of amitriptyline or&#xD;
                  nortriptyline (i.e., CGI-I score ≥4)&#xD;
&#xD;
               -  an inability to tolerate the medication (i.e., side effects)&#xD;
&#xD;
          -  Subjects must pass the TMS Safety Checklist Adult Safety Screen (TASS).&#xD;
&#xD;
          -  Subjects should be off medication, which can lower seizure thresholds (e.g.,&#xD;
             amitriptyline and nortriptyline) for at least two weeks prior to study entry.&#xD;
&#xD;
          -  Subjects with neuropathic pain including those with diagnosis of spinal cord injury,&#xD;
             fibromyalgia, compression neuropathies (including diabetic peripheral neuropathy),&#xD;
             post stroke pain, and multiple sclerosis&#xD;
&#xD;
          -  Subjects with a baseline VAS score greater than 30&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current or past history of a seizure disorder (e.g., epilepsy)&#xD;
&#xD;
          -  Current history of preeclampsia&#xD;
&#xD;
          -  Current or history of brain lesions (e.g., aneurysm)&#xD;
&#xD;
          -  History of major head trauma (e.g., stroke; previous cranial neurosurgery)&#xD;
&#xD;
          -  Ferromagnetic metal in the head, neck, or chest (e.g., plates or pins, bullets,&#xD;
             shrapnel)&#xD;
&#xD;
          -  Microprocessor implants in the head (e.g., cochlear implants) or life-sustaining&#xD;
             microprocessor implants anywhere in the body (e.g., prosthetic cardiac valves)&#xD;
&#xD;
          -  Cardiac pacemaker&#xD;
&#xD;
          -  Active or inactive implants (e.g., deep brain stimulators, vagus nerve stimulators)&#xD;
&#xD;
          -  Active treatment with medications that lower seizure threshold (e.g., bupropion,&#xD;
             amitriptyline, nortriptyline, or other TCA)&#xD;
&#xD;
          -  Increased intracranial pressure (which lowers seizure threshold)&#xD;
&#xD;
          -  Implanted medication pumps&#xD;
&#xD;
          -  Intracardiac lines&#xD;
&#xD;
          -  Significant heart disease defined as heart disease that causes moderate to severe&#xD;
             symptoms and/or is characterized by moderate to severe pathology, including a recent&#xD;
             history of myocardial infarction and heart failure with an ejection fraction of less&#xD;
             than 30% or with a New York Heart Association Functional Classification of Class III&#xD;
             or IV.&#xD;
&#xD;
          -  Bipolar disorder (to reduce the risk of mania)&#xD;
&#xD;
          -  History of suicide attempt(s)&#xD;
&#xD;
          -  Family history of epilepsy&#xD;
&#xD;
          -  Heavy alcohol consumption within the past 48 hours&#xD;
&#xD;
          -  Permanent makeup or tattoos with metallic dyes&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shona L Ray-Grififth, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arkansas For Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>November 13, 2015</study_first_submitted>
  <study_first_submitted_qc>November 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2015</study_first_posted>
  <results_first_submitted>June 23, 2020</results_first_submitted>
  <results_first_submitted_qc>August 17, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 2, 2020</results_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>neuropathic pain</keyword>
  <keyword>pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 30, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT02608463/Prot_002.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 30, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT02608463/SAP_003.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Part A: Neuropathic Pain Group</title>
          <description>≥13 on the painDETECT Questionnaire (PDQ) 10 subjects</description>
        </group>
        <group group_id="P2">
          <title>Part A: Non-Neuropathic Pain Group</title>
          <description>≥1 and ≤12 on the PDQ 5 subjects</description>
        </group>
        <group group_id="P3">
          <title>Part A: Controls</title>
          <description>Patients without neuropathic pain receiving care as usual.</description>
        </group>
        <group group_id="P4">
          <title>Part B Participants</title>
          <description>No participants were ever enrolled in Part B, so this group has been dropped from all future sections.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0">No study participants were enrolled in Part B.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>0 subjects met criteria to be assigned to the &quot;control&quot; group</population>
      <group_list>
        <group group_id="B1">
          <title>Neuropathic Pain Group</title>
          <description>≥13 on the painDETECT Questionnaire (PDQ)</description>
        </group>
        <group group_id="B2">
          <title>Non-Neuropathic Pain Group</title>
          <description>score of ≥1 or ≤12 on the PDQ</description>
        </group>
        <group group_id="B3">
          <title>Controls</title>
          <description>Patients without neuropathic pain receiving care as usual.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="5"/>
            <count group_id="B3" value="0"/>
            <count group_id="B4" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.4" lower_limit="24" upper_limit="37"/>
                    <measurement group_id="B2" value="29.4" lower_limit="24" upper_limit="36"/>
                    <measurement group_id="B4" value="29.4" lower_limit="24" upper_limit="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline Visual Analogue Scale for Pain</title>
        <description>100 mm line scale that is subject administered to subjectively rate current pain symptoms. The subject will be instructed to draw a single vertical line that best describes current state. The total score ranges from 0-100 with higher numbers indicating worse outcomes. The VAS will be administered at every subject visit.</description>
        <time_frame>Baseline and end of study participation, an average of 194 days</time_frame>
        <population>No subjects were ever assigned to the control group, so no stats were performed on this group</population>
        <group_list>
          <group group_id="O1">
            <title>Neuropathic Pain Group</title>
            <description>≥13 on the painDETECT Questionnaire (PDQ) 10 subjects</description>
          </group>
          <group group_id="O2">
            <title>Non-Neuropathic Pain Group</title>
            <description>≥1 and ≤12 on the PDQ 5 subjects</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>Patients without neuropathic pain receiving care as usual. Due to n=0, no statistical analysis was completed.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline Visual Analogue Scale for Pain</title>
          <description>100 mm line scale that is subject administered to subjectively rate current pain symptoms. The subject will be instructed to draw a single vertical line that best describes current state. The total score ranges from 0-100 with higher numbers indicating worse outcomes. The VAS will be administered at every subject visit.</description>
          <population>No subjects were ever assigned to the control group, so no stats were performed on this group</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.57" lower_limit="-18.26" upper_limit="17.12"/>
                    <measurement group_id="O2" value="-14.4" lower_limit="-47.02" upper_limit="18.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Average length of study participation: 194 days; Range: 112-259 days</time_frame>
      <desc>None of the subjects met criteria to be assigned to the &quot;control&quot; group</desc>
      <group_list>
        <group group_id="E1">
          <title>Neuropathic Pain Group</title>
          <description>score of ≥13 on the PDQ&#xD;
Total Serious Adverse Events: 6 Number of Participants Affected by Serious Adverse Events: 3&#xD;
Total Adverse Events: 62 Number of Participants Affected by Adverse Events: 8</description>
        </group>
        <group group_id="E2">
          <title>Non-Neuropathic Pain Group</title>
          <description>score of ≥ 1 or ≤ 12 on the PDQ&#xD;
Total Serious Adverse Events: 40 Number of Participants Affected by Serious Adverse Events: 3&#xD;
Total Adverse Events: 39 Number of Participants Affected by Adverse Events: 5</description>
        </group>
        <group group_id="E3">
          <title>Controls</title>
          <description>score of 0 on the PDQ&#xD;
Total Serious Adverse Events: 0 Number of Participants Affected by Serious Adverse Events: 0&#xD;
Total Adverse Events: 0 Number of Participants Affected by Adverse Events: 0</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypochloremia</sub_title>
                <description>Start Date: 11/26/2017 End Date: 12/06/2017 4 - Unrelated to Study Device 5 - IV fluids &amp; medications</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Patent Ductus Arteriosus</sub_title>
                <description>Admitted to NICU, given ECHO</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary arrest with successful resuscitation</sub_title>
                <description>Start Date: 12/06/2017 End Date: 12/06/2017 4 - Unrelated to Study Device 5 - CPR</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Microtia</sub_title>
                <description>Start Date: 8/28/2017 End Date: Ongoing 4 - Unrelated to Study Device 5 - Intervention CT Scan &amp; Hearing evaluations</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Microstomia</sub_title>
                <description>Start Date: 8/28/2017 End Date: Ongoing 4 - Unrelated to Study Device 5 - Placed gastrostomy tube &amp; CT Scan</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Cleft Palate</sub_title>
                <description>Start Date: 8/28/2017 End Date: Ongoing 4 - Unrelated to Study Device 5 - discovered 5/4/2018 in clinical exam</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Bilateral superior vena cava without bridging vein</sub_title>
                <description>Start Date: 8/28/2017 End Date: Ongoing 4 - Unrelated to Study Device 5 - admitted to NICU &amp; given ECHO</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Bilateral Club Feet</sub_title>
                <description>Start Date: 8/28/2017 End Date: Ongoing 4 - Unrelated to Study Device&#xD;
1 - discovered in clinical exam</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Glossoptosis</sub_title>
                <description>Start Date: 8/28/2017 End Date: Ongoing 4 - Unrelated to Study Device 5 - gastrostomy feeding tube</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <description>Glucose given, NICU</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dysphagia</sub_title>
                <description>Start Date: 8/28/2017 End Date: Ongoing 4 - Unrelated to Study Device 5 - placed gastrostomy tube &amp; speech therapy evaluation</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperbilirubinemia</sub_title>
                <description>Start date: 8/28/2019 End date: Ongoing 4 - Unrelated to Study Device 5- Intervention Phototherapy</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <description>Start Date: 11/10/2016 End Date: 11/12/2016 4 - Unrelated to Study Device 5 - NICU Admission</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection of Tracheotomy</sub_title>
                <description>Start Date: 09/24/2017 End Date: 9/30/2017 4 - Unrelated to Study Device 5 - antibiotics &amp; culture</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Acinetobacter Infection of GT site</sub_title>
                <description>Start Date: 10/20/2017 End Date: 10/30/2017 4 - Unrelated to Study Device 5 - cultured infection &amp; antibiotics</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Moraxella catarrhalis &amp; HFLU Pneumonia</sub_title>
                <description>Start Date: 12/04/2017 End Date: Ongoing 4 - Unrelated to Study Device 5 - Culture &amp; antibiotics</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Rhinovirus Bronchitis</sub_title>
                <description>Start Date: 11/21/2017 End Date: Ongoing 4 - Unrelated to Study Device 5 - medication</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Incision Infection</sub_title>
                <description>Start Date: 03/04/2017 End Date: Ongoing 4 - Unrelated to Study Device 5 - Surgery &amp; Wound Care</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <description>Start Date: 12/08/2016 End Date: 02/16/2017 4 - Unrelated to Study Device 5 - Antibiotic, cough syrup, admission to hospital</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Meconium Aspiration</sub_title>
                <description>Start Date: 04/20/2017 End Date: 04/22/2017 4 - Unrelated to Study Device 5 - NICU Admission</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Metabolic ketoacidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Severe Retro-Micrognathia with Critical Airway</sub_title>
                <description>Start Date: 8/28/2017 End Date: Ongoing 4 - Unrelated to Study Device 5- Intervention Tracheotomy</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Vertebral Anomalies</sub_title>
                <description>Start Date: 8/28/2017 End Date: Ongoing 4 - Unrelated to Study Device 5 - Chest X-Rays &amp; consulted orthopedics</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Shortened Femurs</sub_title>
                <description>Start Date: 8/28/2017 End Date: Ongoing</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Teratologic Hips</sub_title>
                <description>Start Date: 9/1/2017 End Date: Ongoing 4 - Unrelated to Study Device&#xD;
1 - discovered by abdominal x-ray</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>seizure-like activity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Premature Rupture of Membranes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Preterm Delivery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Patent foramen ovale</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperactive Delirium</sub_title>
                <description>Start Date: 11/20/2017 End Date: Ongoing 4 - Unrelated to Study Device 5 - Medications for Sedation</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Preeclampsia</sub_title>
                <description>Start Date: 11/10/2016 End Date: 11/10/2016 4 - Unrelated to Study Device 5 - Emergency C-section</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Pre-Term Labor</sub_title>
                <description>Start Date(s): 03/04/2017; 01/10/2017 End Date(s): 03/04/2017; 01/11/2017 4 - Unrelated to Study Device 5 - Emergency C-section</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Hellp Syndrome (Atypical)</sub_title>
                <description>Start Date: 04/15/2017 End Date: 04/20/2017 4 - Unrelated to Study Device 5 - Hospital &amp; Nifedipine</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory Distress</sub_title>
                <description>Intubated, ventilator support, NICU</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Transient Trachypnea</sub_title>
                <description>Start Date: 04/20/2017 End Date: 04/22/2017</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Severe Retro-Micrognathia with critical airway</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Medical neglect of child by caregiver</sub_title>
                <description>Start Date: 11/21/2017 End Date: Ongoing 4 - Unrelated to Study Device 5 - DHS Report</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Neonatal Abstinence Syndrome</sub_title>
                <description>Start Date(s): 04/15/2017; 04/15/2017 End Date(s): 04/29/2017; 04/29/2017 4 - Unrelated to Study Device 5 - NICU Admission</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Dry Mouth</sub_title>
                <description>Start Date: 01/26/2017 End Date: Ongoing 4 - Unrelated to Study Device 3 - Not recovered / resolved</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Bilateral Feet Edema</sub_title>
                <description>Start Date: 10/24/2016 End Date: 10/27/2016 4 - Unrelated to study device&#xD;
1 - recovered / resolved</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Vision Changes</sub_title>
                <description>Start Date: 11/17/2016 End Date: 12/16/2016 4 - Unrelated to Study Device&#xD;
1- Recovered / Resolved</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <description>Start Date(s): 02/23/2017; 11/03/2016; 11/17/2016; 08/31/2016; 02/16/2017; 12/01/2016; 02/26/2017; 04/27/2017; 06/29/2017; 08/10/2017 4- Unrelated to Study Device 5 - Recovered Resolved</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <description>Start Date(s): 02/23/2017; 12/01/2016; 02/26/2017; 04/27/2017 4 - Unrelated to study device&#xD;
1 - Recovered / Resolved</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Heartburn</sub_title>
                <description>Start Date(s): 11/17/2016; 11/16/2016; 06/29/2017 4 - Unrelated to Study Device&#xD;
1 - Recovered / resolved</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <description>Start Date: 10/26/2016; 12/21/2016; 06/29/2017; 04/13/2017 End Date: 11/02/2016; 12/28/2016; 06/29/2017; 05/24/2017 4 - Unrelated to study device&#xD;
1 - resolved / recovered</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Abdominal Cramps</sub_title>
                <description>Start Date: 05/23/2017 End Date: 07/17/2017 4 - unrelated to study device&#xD;
1 - resolved / recovered</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Hemorrhoid</sub_title>
                <description>Start Date: 02/23/2017; 06/29/2017 End Date: Ongoing 4 - unrelated to study device 3 - not resolved / recovered</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Tooth pain or Absess</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Weight Loss</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <description>Start Date: 06/29/2017 End Date: Ongoing 4 - unrelated to study device 3 - not resolved / recovered</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Weight Gain</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <description>Start Date: 04/27/2017 End Date: Ongoing 4 - unrelated to study device 3 - not resolved / recovered</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Cellulitis at gastrostomy tube site</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Lip Tie</sub_title>
                <description>Start Date: 05/27/2017 End Date: Ongoing 4 - Unrelated to study device 4 - Residual effects present, not treated</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergies</sub_title>
                <description>Start Date(s): 08/31/2017; 04/27/2017 4 - Unrelated to study device&#xD;
1 - recovered / resolved</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Skin Burning</sub_title>
                <description>Start Date: 05/27/2017 End Date: 05/27/2017 4 - unrelated to study device&#xD;
1 - resolved / recovered</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dizzy Spells</sub_title>
                <description>Start Date: 02/23/2017 End Date: Ongoing 4 - Unrelated to study device 2 - Recovering / Resolving</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Muscle Spasms</sub_title>
                <description>Start Date(s): 01/26/2017; 12/22/2016 End Date(s): Ongoing 4 - Unrelated to study device 3 - Not recovered / resolved</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Hip Pain</sub_title>
                <description>Start Date: 10/20/2016; 09/22/2016; 05/04/2017; 02/02/2017 4 - Unrelated to study device&#xD;
1 - Recovered / Resolved</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Carpel Tunnel</sub_title>
                <description>Start Date: 10/20/2016 End Date: Ongoing 4 - Unrelated to Study Device 3 - Not recovered / resolved</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Back Pain</sub_title>
                <description>Start Date: 09/22/2016 End Date: Ongoing 4 - Unrelated to study device 3 - not recovered / resolved</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Right Ankle Pain</sub_title>
                <description>Start Date: 05/08/2017 End Date: 06/22/2017 4 - Unrelated to study device&#xD;
1 - recovered / resolved</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <description>Start Date: 06/29/2017 End Date: Ongoing 4 - unrelated to study device 3 - not resolved / recovered</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Cramping</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Pain Increase</sub_title>
                <description>Start Date(s): 10/27/2016; 12/01/2016; 11/17/2016; 12/22/2016; 02/16/2017; 11/17/2016; 07/13/2017; 12/01/2016; 12/01/2016; 04/06/201; 06/01/2017; 04/13/2017; 05/11/2017; 05/18/2017; 08/10/2017</description>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Headaches</sub_title>
                <description>Start Date(s): 11/17/2016; 06/05/2017;02/13/2017; 04/27/2017; 11/03/2016;12/01/2016; 06/01/2017; 05/18/2017; 08/03/2017 4 - Unrelated to Study Device 3 - Resolved / Recovered</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Anesthesia Difficulty</sub_title>
                <description>Start Date: 12/16/2016 End Date: 12/16/2016 4 - Unrelated to study device&#xD;
1 - Recovered / Resolved</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <description>Start Date: 05/15/2017 End Date: 05/15/2017 4 - unrelated to study device&#xD;
1 - resolved / recovered</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Numbness/tingling of bilateral hands</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depressed Mood</sub_title>
                <description>Start Date(s): 10/27/2016; 09/22/2016; 07/13/2017; 05/26/2017; 12/01/20160; 6/01/2017; 06/08/2017; 04/13/2017; 05/18/2017; 07/13/2017; 08/10/2017f 4 - Unrelated to study device 2 - recovering / resolving</description>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <description>Start Date(s): 08/25/2016; 11/03/2016; 02/16/2017; 10/17/2016; 08/31/2016; 12/01/2016; 04/06/2017; 02/23/2017; 04/13/2017; 06/08/2017; 06/15/2017; 04/27/2017; 08/10/2017 4- Unrelated to the study device&#xD;
1 - resolved / recovered</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <description>Start Date(s): 08/25/2016; 08/23/2017 4 - Unrelated to the study device&#xD;
1 - Recovered / Resolved</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <description>Start Date(s): 12/22/2016; 02/09/2017; 03/02/2017; 04/13/2017 4 - Unrelated to study device 3 - not recovered / resolved</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Hypervigilance</sub_title>
                <description>Start Date: 01/26/2017 End Date: Ongoing 4 - Unrelated to Study Device 3 - Not recovered / resolved</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Drowsiness or sedation</sub_title>
                <description>Start Date: 09/22/2016; 12/12/2016 4 - Unrelated to study device 6 - Unknown</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <description>Start Date(s): 02/16/2017; 10/17/2016 End Date: Ongoing 4 - Unrelated to study device 3 - not resolved / recovered</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Postpartum Depression</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Flank Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Low Lying Kidneys</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Braxton Hicks Contractions</sub_title>
                <description>Start Date: 10/09/2016 End Date: 11/10/2016 4 - Unrelated to the study device&#xD;
1- Recovered / Resolved</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Vaginal Bleeding</sub_title>
                <description>Start Date: 10/27/2016; 02/23/2017 End Date: 10/27/2016; 03/16/2017 4 - Unrelated to study device&#xD;
1 - recovered / resolved</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Bacterial Vaginosis</sub_title>
                <description>Start Date: 02/05/2017 End Date: 02/16/2017 4 - Unrelated to study device&#xD;
1 - resolved / recovered</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <description>Start Date: 02/10/2017 End Date 03/019/2017 4 - unrelated to study device&#xD;
1 - resolved / recovered</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Yeast Infection</sub_title>
                <description>Start Date: 02/10/2017 End Date: 02/16/2017 4 - unrelated to study device&#xD;
1 - resolved / recovered</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Mastitis</sub_title>
                <description>Start Date: 05/26/2017 End Date: Ongoing 4 - unrelated to study device 3 - not resolved / recovered</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Preterm Labor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <description>Start Date: 04/13/2017 End Date: 05/11/2017 4 - unrelated to study device&#xD;
1 - resolved / recovered</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Rhinorrhea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Eczema</sub_title>
                <description>Start Date: 09/22/2016 End Date: Ongoing 4 - Unrelated to the study device 6 - Unknown</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Bilateral Hand Edema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Diaper Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Early termination due to inability to enroll pregnant subjects into the TMS intervention portion (Part B) of the study.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Shona Ray-Griffith</name_or_title>
      <organization>University of Arkansas for Medical Sciences</organization>
      <phone>501-526-8428</phone>
      <email>slray@uams.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

